CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04729361

Enrollment

150

Registered

2021-01-28

Start date

2021-01-31

Completion date

2021-11-30

Last updated

2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Disease, IUGR, Prenatal Disorder

Brief summary

According to french recommandations for IUGR management we have to propose a CGH-array analysis if the IUGR is severe (bellow the 3rd percentile) and early (in the second trimester). However there is no data to support this point of view.

Interventions

GENETICCGH array analysis

CGH array analysis

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* pregnant women * fetus with an isolated intra-uterine growth restriction (IUGR) severe (bellow the third percentile on CFEF curves) and early (between 21 and 24 gestational weeks).

Exclusion criteria

* associated IUGR (with other abnormalities during prenatal screening)

Design outcomes

Primary

Measure	Time frame
rate of abnormal CGH-array in the groupe severe and early UGR	one-time (at the time of the analysis)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026